Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1543-1549

  Schoffer, Kerrie L ^a,c   Henderson, Robert D ^a,b   O'Maley, Karen ^a   O'Sullivan, John D ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Domperidone; Fludrocortisone; Nonpharmacological therapy; Orthostatic hypotension; Parkinson's disease

Indexed keywords

DOMPERIDONE; FLUDROCORTISONE; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; HEART PALPITATION; HUMAN; MALE; MORNING SICKNESS; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT SAFETY; POINT OF CARE TESTING; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SPHYGMOMANOMETER; THORAX PAIN; TILT TABLE TEST; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; CROSS-OVER STUDIES; DOMPERIDONE; DOPAMINE ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; FLUDROCORTISONE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; PARKINSON DISEASE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPHYGMOMANOMETERS; TILT-TABLE TEST;

EID: 34748866218     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21428     Document Type: Article

References (33)

1. Consensus Statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci 1996;144:218-219.
2. Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:584-589.
3. Elmstahl S, Rosen I. Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women. Dement Geriatr Cogn Disord 1997;8:180-187.
4. Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000;31:2307-2313.
5. Rose JM, Tyroler HA, Narndo CJ, et al. Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Hypertens 2000;13:571-578.
6. Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 1998;98:2290-2295.
7. Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997;7:321-326.
8. Van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res 2000;10:35-42.
9. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans : a sympathetic reflex? Circulation 2000;101:504-509.
10. Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 1999;53:2151-2157.
11. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 2003;74:1294-1298.
12. Nair B, Leitch J. Erythropoietin treatment for postural hypotension from autonomic dysfunction. Aust N Z J Med 1996;26:859-860.
13. Miller E, Wiener L, Bloomfield D. Etilefrine in the treatment of L-dopa-induced orthostatic hypotension. Arch Neurol 1973;29:99-103.
14. Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind placebo-controlled study with midodrine. Am J Med 1993;95:38-48.
15. Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension. JAMA 1997;277:1046-1051.
16. Bordet R, Benhadjali J, Libersa C, Destee A. Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration. J Clin Neuropharmacol 1994;17:380-383.
17. Hoehn MM. L-Dopa-induced postural hypotension. Treatment with fludrocortisone. Arch Neurol 1975;32:50-51.
18. Hakamaki T, Rajala T, Lehtonen A. Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with or without fludrocortisone. Int J Clin Pharmacol Ther 1998;36:367-369.
19. Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging 2001;18:495-505.
20. Lang AE. Acute orthostatic hypotension when starting dopamine agonist therapy in parkinson disease: the role of domperidone therapy. Arch Neurol 2001;58:835.
21. Capria A, Attanasio A, Quatrana M, et al. Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease. Clin Neuropharmacol 1989;12:331-338.
22. Merello M, Pirtosek Z, Bishop S, Lees AJ. Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine. Clin Auton Res 1992;2:215-219.
23. Lopes de Faria SR, Zanella MT, Andriolo A, Ribeiro AB, Chacra AR. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension. Clin Pharmacol Ther 1988;44:670-674.
24. Destee A, Leys D, Delisse B, Warot P. Orthostatic hypotension due to diabetic autonomic neuropathy? Treatment with domperidone. Arch Neurol. 1987;44:11.
25. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
26. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
27. Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'Brien PC, Low PA. The autonomic symptom profile: a new instrument to assess autonomic symptoms. Neurology 1999;52:523-528.
28. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-752.
29. Urbaniak GC, Plous S. http://www.randomizer.org. 1997-2005.
30. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orhostatic intolerance in patients with unexplained syncope. Heart 1996;75:134-140.
31. Smit AA, Wieling W, Fujimura J, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res 2004;14:167-175.
32. Bouvette CM, McPhee BR, Opfer-Gehrking TL, Low PA. Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation. Mayo Clin Proc 1996;71:847-853.
33. Sigurdardottir GR, Nilsson C, Odin P, Grabowski M. Cardiovascular effects of domperidone in patients with Parkinson's disease treated with apomorphine. Acta Neurol Scand 2001;104:92-96.